Boston Scientific Corp. (BSX) News
Filter BSX News Items
BSX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BSX News Highlights
- BSX's 30 day story count now stands at 15.
- Over the past 23 days, the trend for BSX's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- AMP, LI and LINK are the most mentioned tickers in articles about BSX.
Latest BSX News From Around the Web
Below are the latest news stories about BOSTON SCIENTIFIC CORP that investors may wish to consider to help them evaluate BSX as an investment opportunity.
Boston Sci sees Farapulse PFA receiving FDA approval in Q1More on Boston Scientific |
Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial FibrillationBoston Scientific Corporation (NYSE: BSX) has initiated the AVANT GUARD clinical trial to evaluate the safety and effectiveness of the FARAPULSE™ Pulsed Field Ablation (PFA) System* as a first-line treatment for persistent atrial fibrillation (AF), the only trial to study the use of PFA as frontline therapy in patients with this form of AF. Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to ou |
3 Medical-Device Stocks Could Click in 2024Baird is bullish on Boston Scientific, Insulet, and DexCom, stocks set to benefit as those companies ramp up sales. |
Show Me The Money: Inside Ken Griffin's Citadel's Jaw-Dropping $7 Billion ReturnCitadel Founder and CEO Ken Griffin is one of the most successful investors of all time, managing over $62 billion in assets. He is also the founder of Citadel Securities, the largest market-making firm for the New York Stock Exchange and one of the largest designated market makers in the world. Citadel Securities is involved in one out of four stock trades placed in U.S. exchanges and nearly 40% of all retail trades. With a net worth of $37.5 billion, Griffin is one of the richest hedge fund ma |
Insider Sell Alert: EVP Wendy Carruthers Sells 11,672 Shares of Boston Scientific Corp (BSX)Boston Scientific Corp (NYSE:BSX), a leading innovator in medical solutions that improve the health of patients around the world, has recently witnessed a significant insider sell by one of its top executives. |
UPDATE 1-Business travel emissions drop as many firms fly less -surveyAlmost half of 217 global firms cut their business travel carbon emissions by at least 50% between 2019 and 2022, analysis published on Monday found, as corporate air travel returned at a much slower pace since the pandemic than leisure flights. Despite a global rebound, business travel has been slow to return to 2019 levels, with many corporate clients turning to video conferencing or rail trips rather than flying. Global business travel firms say this trend could hit corporate relationships. |
PBH or BSX: Which Is the Better Value Stock Right Now?PBH vs. BSX: Which Stock Is the Better Value Option? |
Boston Scientific (BSX) Hits 52-Week High: What's Aiding It?Investors are optimistic about Boston Scientific's (BSX) impressive market share gain in the MedSurg segment. |
Medtronic snags first pulsed field ablation approval in USThe treatment for atrial fibrillation has gained attention as a safer alternative to radiofrequency and cryoablation. Boston Scientific and Johnson & Johnson are also pursuing the PFA market. |
Billionaire Ken Griffin's Citadel Returned a Whopping $7 Billion to Investors -- These Are 3 of Its Biggest HoldingsThese two stocks and one ETF helped the billionaire's hedge fund make a boatload of money in 2023. |